Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling.

@article{OliverasFerraros2008SequencedependentSA,
  title={Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling.},
  author={Cristina Oliveras-Ferraros and Alejandro V{\'a}zquez-Mart{\'i}n and R Colomer and Rafael de Llorens and Joan Brunet and Javier A. Men{\'e}ndez},
  journal={International journal of oncology},
  year={2008},
  volume={32 1},
  pages={113-20}
}
The marked clinical anticancer activity of the paclitaxel (PTX) and gemcitabine (GEM) combination has suggested that the two drugs may interact more than additively. We have analyzed the in vitro growth and molecular interactions of the two chemotherapy drugs in a panel of human breast cancer cells. We evaluated cell viability in four breast cancer cell… CONTINUE READING